Discover 520 paid clinical trials in Cedar Rapids, Iowa. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 520
Active & Responsive
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: Iowa City IA, Madison WI, Rochester MN, St Louis MO,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 2+
Code: NCT06789913
Phase2, Recruiting
Active & Responsive
Evaluation of the Automated Integration of a Robotics and ECochG System for Use With Cochlear Implant Surgery
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
for
Huntington Disease
Location: Iowa City IA, Madison WI, Chicago IL, Fairway KS,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 21 - 70
Code: NCT07326709
Phase3, Recruiting
Active & Responsive
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Iowa City IA, Liberty MO, Louisville KY, Mentor OH,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT06233461
Phase2, Recruiting
Active & Responsive
Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
for
Friedreich Ataxia
Location: Iowa City IA, Columbus OH, Memphis TN, Toronto,
Sponsor: Friedreich's Ataxia Research Alliance
Sex: All
Age: 0+
Code: NCT06016946
Recruiting
Active & Responsive
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
Location: Iowa City IA, Chicago IL, Minneapolis MN, St Louis MO,
Sponsor: PedAL BCU, LLC
Sex: All
Age: 0 - 21
Code: NCT05183035
Phase3, Recruiting
Active & Responsive
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
for
Spinal Muscular Atrophy (SMA)
Location: Iowa City IA, Chicago IL, Little Rock AR,
Sponsor: argenx
Sex: All
Age: 5 - 17
Code: NCT07287982
Phase2, Recruiting
Active & Responsive
Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer,
Location: Iowa City IA, Chicago IL, Saint Louis Park MN, Omaha NE,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT06901531
Phase3, Recruiting
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
for
Pleuropulmonary Blastoma
Location: Iowa City IA, Madison WI, Rochester MN, Chicago IL,